miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MaP2K7.

Autor: Liquan Hong1, Feng Pan1, Huifen Jiang2, Lahong Zhang1, Yuhua Liu1, Chengsong Cai1, Chunzhen Hua3, Xian Luo1, Jinhua Sun4, Zhaojun Chen1
Zdroj: OncoTargets & Therapy. May2016, Vol. 9, p2639-2648. 10p.
Databáze: Academic Search Ultimate